Digital therapeutics (DTx) were gaining popularity as tools to help slash the US’ $3 trillion annual spending on chronic disease, and the pandemic has vaulted digital therapies into the spotlight. Now, the Teladoc-Livongo megamerger is heating up competition in the DTx space as players race to capture a slice of a market slated to reach $56 billion by 2025.

The reports in this collection look at ad spending in the retail, financial services, computing products and consumer electronics, automotive, telecom, travel, health and pharma, media and entertainment, and CPG industries. Countries covered in this report series include the US, UK, and Germany.

Digital ad spending in the US healthcare and pharmaceutical industry will grow by 14.2% to reach $9.53 billion in 2020. Growth is being fueled by ads related to COVID-19, including public service announcements, medical supplies and telemedicine.

US B2B digital ad spending in 2020 will grow 22.6% year over year amid the coronavirus pandemic. This report breaks down the market factors and B2B-specific considerations that are driving this increase.

This report provides an overview of the most important technology trends from CES 2020 and what they mean for marketers.

Healthcare and pharma ad spend is growing at a similar pace to other verticals, but FDA regulations and strict privacy laws restrict overall budgets.

Digital ad spending in Germany will approach €7.3 billion ($8.6 billion) this year—nearly 10% more than in 2018. The sectors we analyze—including automotive, consumer packaged goods (CPG), financial services, healthcare/pharma, retail and travel—will all see much higher spending on mobile ads.

This report provides an overview of the most important technology at CES 2019 and what it means for marketers, now and in the future.